News

Hims & Hers: Peptide And Short Squeeze Are Coming!
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
What’s Happening With HIMS Stock?
HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...
CNBCTV1816h
Delhi HC restrains Dr Reddy’s, OneSource in Novo Nordisk weight loss drug patent case
The court’s intervention comes at a crucial time as Novo Nordisk gears up for the rollout of Wegovy, amid rising global ...